计算溶液所需的质量、体积或浓度。
Casirivimab (anti-Spike RBD) (Ab182896) - ELISA
Immobilized Human Spike RBD protein ( rp155929) at 1.0 μg/mL can bind Casirivimab (anti-Spike RBD) (Ab182896) with the EC50 of 10.50 ng/mL.
Casirivimab (anti-Spike RBD) 是一种人的单克隆抗体,靶向导致 COVID-19 的 SARS-CoV-2 病毒。Casirivimab (anti-Spike RBD) 对 COVID-19 变种缺乏疗效。Casirivimab (anti-Spike RBD) 可与 Imdevimab 联合使用,有效降低病毒载量,改善病症。
Casirivimab (anti-Spike RBD) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Casirivimab (anti-Spike RBD) lacks efficacy against COVID-19 variants. Casirivimab (anti-Spike RBD) can be used in combination with Imdevimab, it reduces viral load and improves diseases.
Casirivimab (anti-Spike RBD) (Ab182896) - ELISA
Immobilized Human Spike RBD protein ( rp155929) at 1.0 μg/mL can bind Casirivimab (anti-Spike RBD) (Ab182896) with the EC50 of 10.50 ng/mL.
Casirivimab (anti-Spike RBD) (Ab182896) - SEC
The purity of Casirivimab (anti-Spike RBD) (Ab182896) is more than 95% verified by HPLC.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab182896 | |
| 分析证书 | Ab182896 | |
| 分析证书 | Ab182896 |
我们的级别选择指南涵盖了目录中所有的变体的纯度、稳定剂状态和应用适用性。
查看 Animal Free 级别指南 → 查看 Carrier Free 级别指南 → 查看 Recombinant 级别指南 → 查看 Validated 级别指南 → 查看 ExactAb™ 级别指南 → 查看 Low Endotoxin 级别指南 → 查看 Azide Free 级别指南 →